Novo Financial Statements From 2010 to 2025
Novo Integrated financial statements provide useful quarterly and yearly information to potential Novo Integrated Sciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Novo Integrated financial statements helps investors assess Novo Integrated's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Novo Integrated's valuation are summarized below:Novo Integrated Sciences does not presently have any fundamental ratios for analysis.
This module can also supplement various Novo Integrated Technical models . Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Check Novo Integrated financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novo Integrated's main balance sheet or income statement drivers, such as , as well as many indicators such as . Novo financial statements analysis is a perfect complement when working with Novo Integrated Valuation or Volatility modules.
Novo |
Novo Integrated Sciences Company Return On Equity Analysis
Novo Integrated's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Novo Integrated Return On Equity | -1.35 |
Most of Novo Integrated's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Novo Integrated Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Novo Integrated Sciences has a Return On Equity of -1.3542. This is 94.35% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Novo Integrated Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Novo Integrated's current stock value. Our valuation model uses many indicators to compare Novo Integrated value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Novo Integrated competition to find correlations between indicators driving Novo Integrated's intrinsic value. More Info.Novo Integrated Sciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Novo Integrated's earnings, one of the primary drivers of an investment's value.Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Novo Pink Sheet
If you are still planning to invest in Novo Integrated Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Novo Integrated's history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |